Wednesday November 21, 2018 13:27

Heathcare Press Release : 06 Mar 2018

ViiV Healthcare Announces Positive New Dolutegravir Data for the Treatment of People Living With Heathcare—06 Mar 18

INSPIRING study results contribute to the extensive body of evidence for dolutegravir, the leading integrase strand transfer inhibitor, in diverse and hard to treat patient populations ViiV Healthcare, the global specialist HIV company, majority owned